Modifications of DNA and chromatin are fundamental for the establishment and maintenance of cell type-specific gene expression patterns that constitute cellular identities. To test whether the developmental potential of fetal brainderived cells that form floating sphere colonies (neurospheres) can be modified by destabilizing their epigenotype, neurosphere cells were treated with chemical compounds that alter the acetylation and methylation patterns of chromatin and DNA. Intravenous infusion of bulk or clonally derived neurosphere cells treated with a combination of trichostatin A (TSA) plus 5-aza-2 0 -deoxycytidine (AzaC) (TSA/AzaC neurosphere cells) yielded long-term, multilineage and transplantable neurospherederived haematopoietic repopulation. Untreated neurosphere cells exhibited no haematopoietic repopulation activity. The neurosphere-derived haematopoietic cells showed a diploid karyotype, indicating that they are unlikely to be products of cell fusion events, a conclusion strengthened by multicolour fluorescence in situ hybridization. Our results indicate that altering the epigenotype of neurosphere cells followed by transplantation enables the generation of neurosphere-derived haematopoietic cells.
Introduction
The establishment and maintenance of cellular identity of somatic cells including stem cells require a tight control of gene expression. Common as well as distinct gene expression patterns have been observed for different stem cell types (Terskikh et al, 2001; Ivanova et al, 2002; Ramalho-Santos et al, 2002; D'Amour and Gage, 2003) . Chromatin modifications play important roles in determining gene expression (Grewal and Moazed, 2003; Jaenisch and Bird, 2003) . In particular, each gene has an epigenotype defined in terms of its cell type-and developmental stage-specific chromatin organization. Transcription factors binding to their recognition sequences recruit multiprotein complexes, such as chromatin remodelling and histone-modifying factors, which alter the access of regulatory proteins to the DNA template. As a consequence, histones may become acetylated, methylated and phosphorylated. This histone code is read by specific trans-acting factors and defines levels of chromatin organization and gene activity (Jenuwein and Allis, 2001 ). DNA and histone modifications are somatically heritable and the propagation of epigenetic states of the chromatin to the next cell generation is important for maintaining the identity of cells (Avots et al, 2002) .
One type of chromatin modification, the acetylation of histones, occurs reversibly on lysine e-NH 3 þ groups of core histones. Hyperacetylated histones are associated with active chromatin domains, whereas hypoacetylated histones are enriched in nontranscribed loci (Eberharter and Becker, 2002) . The level of histone acetylation depends on the opposing activities of histone acetyltransferases (HATs) and deacetylases (HDACs). Several microbially derived compounds specifically inhibit HDACs (Hassig and Schreiber, 1997) . One of these inhibitors, the Streptomyces metabolite trichostatin A (TSA), a hydroxamic acid, exerts its activity by interacting with the catalytic site of HDACs (Yoshida et al, 1990; Jung, 2001) . TSA indirectly induces acetylation of histones, cell cycle arrest and apoptosis (Johnstone, 2002) . A second epigenetic modification of the vertebrate genome is the methylation of cytosine, predominantly within CpG dinucleotides, which plays a major role in the stable repression of transcription (Bird, 2002; Dillon and Festenstein, 2002) . In adult somatic cells, methylation patterns within the genome are stable. On the other hand, DNA methylation is very dynamic during early development and in certain tumour cells (Schmutte and Jones, 1998) . AzaC is often used as a DNA methylation inhibitor. When incorporated into DNA, it covalently binds to and irreversibly blocks the maintenance methyltransferase Dnmt1, allowing passive demethylation to take place as cells divide and replicate their DNA (Pietrobono et al, 2002) . Previous work described the reactivation of silenced genes by inhibitors of methylation (Lassar et al, 1986) and deacetylation (McCaffrey et al, 1997) and a synergistic effect of both inhibitors in tumour cells (Cameron et al, 1999; Chiurazzi et al, 1999) . Interestingly, in vitro-cultured human CD34
þ haematopoietic stem/progenitor cells retain the ability to repopulate immunodeficient mice if pretreated with AzaC and TSA (Milhem et al, 2004) . Several recent studies have challenged the traditional concept that development is unidirectional and that cells isolated from differentiated tissues are restricted in the types of cells they can generate. Data published on the developmental potential of committed cells showed for example that clonogenic common lymphoid progenitors can maintain a latent myeloid differentiation programme and that they can be redirected to the myeloid lineage by stimulation through exogenously expressed growth factor receptors . Similarly, extracellular signals were reported to induce oligodendrocyte precursors to revert to multipotent neural stem cells (Kondo and Raff, 2000) . Several reports further claimed that stem cells isolated from adult tissues may harbour unexpected developmental plasticity. For example, neurosphere cells were reported to generate haematopoietic cells in vivo, and following injection into blastocysts neurosphere cells gave rise to differentiated cells of all three germ layers (Bjornson et al, 1999; Clarke et al, 2000) . However, the general plasticity of somatic stem and progenitor cells has also been questioned, as haematopoietically competent neurosphere cells were found to be rare and competence was suggested to depend on epigenetic alterations (Morshead et al, 2002) . Other reports further questioned the developmental plasticity of somatic stem cells, as haematopoietic stem cells (HSCs) failed to differentiate into neural cells and transplanted single HSCs did not engraft nonhaematopoietic tissues (Castro et al, 2002; Wagers et al, 2002) . In addition, it was demonstrated that cells can adopt the phenotype of other cells by spontaneous cell fusion, suggesting that the plasticity of somatic stem cells could result from cell fusion (Terada et al, 2002; Ying et al, 2002; Vassilopoulos et al, 2003; Wang et al, 2003) . But not all reported transdifferentiation events are based on cell fusion: neurosphere cells after coculture with endothelial cells converted to endothelial cells; HSCs when cocultured with injured liver separated by a barrier became liver cells; and bone marrow cells generated epithelial cells in lung, liver and skin without cell fusion (Harris et al, 2004; Jang et al, 2004; Wurmser et al, 2004) . Thus, the possibility that somatic stem cells can switch germ layers remains controversial and the available data suggest that transdifferentiation of stem cells is a rare event (Wagers and Weissman, 2004) .
To test whether the developmental potential of neurosphere cells can be modified by destabilizing their epigenetic state, we treated neurosphere cells with the HDAC inhibitor TSA and the nucleotide analogue AzaC. Injection of neurosphere cells treated with a combination of TSA plus AzaC (TSA/AzaC) into adult irradiated recipients generated animals with chimeric haematopoietic systems. We show that TSA/AzaC neurosphere cells give rise to haematopoietic engraftment that is multilineage, long-term and transplantable.
Results
Self-renewal and differentiation of bulk and clonal neurosphere cells Neural stem and progenitor cells form, in culture, floating colonies (neurospheres), which contain both cells that can initiate new colonies and cells that can differentiate into neural and glial cell types (Reynolds and Weiss, 1992) . In our experiments, we utilized neurosphere cells from wildtype (wt) and from bcl2-transgenic embryonic day (E) 14.5 embryos ( Figure 1A) , with expression of the latter gene as protection against the apoptosis-inducing activities of TSA (Koyama et al, 2000; Johnstone, 2002) . Ubiquitous expression of the bcl2 transgene under the control of the mouse H-2K b promoter did not adversely affect embryonic or adult development (Domen et al, 1998) . Under limiting dilution, bcl2-transgenic, as compared to wt, neurospheres showed a limited increase in the numbers of neurosphere-initiating cells ( Figure 1B) . Likewise, bcl2-transgenic mice show a mild increase in HSC numbers (Domen et al, 1998) . Wt and eGFP/bcl2 double transgenic (eGFP/bcl2) neurosphere cells differentiated into GFAP þ (glial fibrilaric acidic protein) astroglial and tubulin beta-III þ neuronal cells ( Figure 1C ).
Neurospheres contain cells that self-renew and differentiate into neural and glial cell types. Figure 2A ). In addition, treated bcl2 and wt neurospheres show reduced proliferation and neurosphere initiation frequencies ( Figure 2B and C) but retain glial and neural differentiation potential (data not shown). Bulk neurospheres were established from male embryos, and then treated and untreated neurospheres were dissociated and intravenously injected into irradiated CD45 congenic female recipients. For animals transplanted with untreated wt or eGFP/bcl2 neurosphere cells, FACS analysis revealed no detectable engraftment of the peripheral blood ( Figure 3 ). In contrast, 2/48 or 5/25 recipients transplanted with the same wt or eGFP/bcl2 neurosphere cell cultures but pretreated with TSA/AzaC had generated donor-derived cells in the peripheral blood that stained with the pan-haematopoietic marker CD45. Donor cells were first detected in the peripheral blood of recipients analysed at 4 weeks posttransplantation. Male-specific PCRs on genomic DNA isolated from peripheral blood further confirmed the donor origin of the cells (data not shown). transplantable ( Figure 4C ). Taken together, the transplantation of bulk TSA/AzaC neurosphere cells from wt and eGFP/ bcl2 origin resulted in long-term and multilineage engraftment of the haematopoietic system of irradiated recipients. As wt and eGFP/bcl2 neurosphere cells differ in TSA/AzaC sensitivity and eGFP/bcl2 neurosphere cells show higher engraftment frequencies, only eGFP/bcl2 neurosphere cells were further investigated.
Cloned neurosphere cells generate multilineage haematopoietic reconstitution with normal haematopoietic cells
To test whether the progeny of a single neurosphere cell have the potential to generate haematopoietic cells in vivo, we established clonal cultures. Three clonal eGFP/bcl2 neurosphere lines were established and transplanted into irradiated recipients. Two of the three clonal lines engrafted and generated CD45.2 þ and eGFP þ donor cells ( Figure 5A and B). As seen with bulk neurosphere cells, only TSA/AzaC-treated but not untreated cloned eGFP/bcl2 neurosphere cells successfully engrafted. Phenotypic analysis of sorted donor cells from bone marrow revealed normal haematopoietic morphology ( Figure 5C ). The haematopoietic differentiation potential of eGFP/bcl2 neurosphere-derived cells was studied by in vitro clonogenic assays of sorted CD45.2 À host and CD45.2 þ donor cells from the bone marrow of chimeric recipients. The frequencies of erythro/myeloid colony-forming cells in the donor and host cell populations were essentially identical ( Figure 5D ). To further characterize the neurosphere-derived cells, we performed immunophenotyping of donor T-and B-lymphoid cells in chimeric animals ( Figure 6A Additionally, bone marrow and spleen of transplant recipients contained neurosphere-derived MAC1 þ myeloid cells ( Figure 6C ). Using four-colour flow cytometry, we assessed the presence of normal combinations of myeloid and lymphoid differentiation markers on donor cells in chimeric bone marrow and spleen. Like their HSC-derived counterparts,
did not express the B-lymphoid marker CD19, nor did they show T-lymphoid-specific CD3 staining. Similarly, donor B-
( Figure 7 ). After transplantation of bone marrow cells from two primary TSA/AzaC neurosphere cell recipients into six secondary recipients each, all secondary recipients were engrafted (data not shown). Our data indicate that transplantation of cloned TSA/AzaC eGFP/bcl2 neurosphere cells into recipient mice results in haematopoietic chimaerism. Donor cells showed normal morphology, produced erythro/myeloid colony-forming cells in clonogenic in vitro cultures and exhibited normal expression of lineage-specific myeloid/ lymphoid differentiation markers. Importantly, none of the primary or secondary recipients displayed signs of haematological malignancies.
To test whether neurosphere cells have in vitro haematopoietic activity, we plated untreated (1 Â10 6 ) and treated (2 Â10 6 bulk and 1 Â10 6 cloned) eGFP/bcl2 neurosphere cells into methylcellulose under haematopoietic growth conditions. While control cultures seeded with bone .1 animals (panels 1 and 5) and of recipients receiving untreated (panels 2 and 6) or treated CD45.1 congenic wt or CD45.2 congenic eGFP/bcl2 neurosphere cells (panels 3 and 7). Animals receiving CD45.1 congenic or eGFP transgenic, CD45.2 congenic bone marrow cells are shown (panels 4 and 8). Recipient #154 is shown in panel 7. Percentages of cells positive for donor or lineage markers are shown. Also shown are summaries of the engraftment (%) in the peripheral blood by wt or eGFP/bcl2 neurosphere-derived cells. Numbers of chimerics per total number of analysed animals are given. Animals were analysed 1.5-2 months after transplantation. The results from wt and bulk eGFP/bcl2 neurosphere cell transplantations were from two and six independent experiments; 2/2 and 3/6 transplantations produced haematopoietic chimaeras. 
Neurosphere-derived haematopoietic cells carry a diploid donor karyotype
It was previously observed that bone marrow and neurosphere cells are both able to fuse with unrelated cell types (Terada et al, 2002; Ying et al, 2002; Vassilopoulos et al, 2003; Wang et al, 2003) . Consequently, cell fate changes of somatic stem cells could be the result of fusion with recipient cells. The high-level chimaerism in haematopoietic tissues described above allows flow cytometric analysis of the DNA content of donor cells. The total DNA content of cells as a marker revealing polyploidy can be determined spectofluorometrically after staining cells with the DNA dye 7-aminoactinomycin D (7-AAD; Schmid et al, 2000) . We injected bulk and clonally derived TSA/AzaC eGFP/bcl2 neurosphere cells isolated from CD45.2 embryos into irradiated CD45.1 congenic recipients. At 3-4 months post-transplantation, splenocytes were isolated from recipients that had received either neurosphere or bone marrow cells from a control mouse. CD45.2 expression, as a marker for transplanted donor cells, was plotted against DNA content ( Figure 8A ). Most splenocytes of control mice were noncycling and had a 2n DNA content, and only a minor population had more than 2n DNA content, indicating cycling. After transplantation of CD45.2 bone marrow cells or treated CD45.2 eGFP/bcl2 neurosphere cells, CD45.2 þ cells were evident in the periphery, and 7-AAD analysis of both donor and recipient splenocytes revealed 2n DNA for the great majority of cells. The minor fraction of cells displaying a 4n DNA is expected due to cell cycling. Importantly, no cells with higher DNA content were detectable. We obtained similar results with peripheral blood cells (data not shown). The distribution of cycling and noncycling cells, revealed by 7-AAD DNA content analysis, is shown on stimulated splenocytes. To determine the karyotype of neurosphere-derived splenocytes, multicolour fluorescence in situ hybridization (M-FISH) analysis was performed ( Figure 8B ). The results indicate in all 20 evaluated metaphase spreads a normal diploid male karyotype (2n). In addition, we determined whether the CD45.1 allele, a marker of recipient cells, and the donor alleles CD45.2 (both chromosome 1) and eGFP (chromosome 15) were present in distinct cells ( Figure 8C ). The CD45.1 and CD45.2 alleles are biallelically expressed (Ema and Nakauchi, 2000 
Discussion
Our studies show that neurosphere cells treated with agents that induce epigenetic modifications generate haematopoietic cells after transplantation into irradiated adult recipients. The neurosphere-derived haematopoietic repopulation of adult recipients is long-term, multilineage and transplantable. Furthermore, neurosphere-derived haematopoietic cells have a 2n donor karyotype, so the induced neural-to-haematopoietic fate change is unlikely to be the result of cell fusion. Our data imply that altering the epigenetic state of neurosphere cells followed by transplantation enables neural-to-haematopoietic fate change.
How fixed is the differentiation state of somatic cells?
Developmental processes are generally regarded as being unidirectional, but several lines of evidence indicate that the commitment and differentiation states of somatic cells are not invariantly fixed. Reprogramming of developmental stage-specific transcription can be achieved by transplanting cells to heterochronic microenvironments. We previously observed the reactivation of embryonic-type gene expression upon transplanting HSCs from adult donors into embryonic microenvironments, and, conversely, that embryonic haematopoietic progenitors express adult-type genes when transplanted to adult environments (Geiger et al, 1998) . Gene expression of differentiated cells can also be reprogrammed by heterokaryon formation. Following muscle cell fusion, a range of muscle functions was induced in fibroblasts, while non-muscle genes were repressed (Blau et al, 1985) . In addition, functional reprogramming of mature fibroblasts into cells with lymphoid character was observed upon incubating them with nuclear or cytoplasmic extracts of T cells (Hakelien et al, 2002) . Reprogramming was to some extent heritable and is believed to depend on loss of nuclear regulatory proteins from recipient nuclei and their replacement by factors from heterologous cellular environments. Finally, the successful cloning of mammals by nuclear transplantation proves that nuclei of differentiated cells can be reprogrammed to a zygotic state when transplanted into an oocyte (Wilmut et al, 1997) . Studies on the frequency of successful cloning using embryonic stem (ES) cells and terminally differentiated cells indicate that cloning is more effective using stem cells rather than differentiated cells as nuclear donors, suggesting that the nucleus of a stem cell is easier to reprogramme (Liu, 2001 ). Thus, the differentiation state of a somatic cell is not inalterably fixed and can be modified by experimental manipulations.
Studies on the influence of the epigenetic state on reprogramming demonstrated that modification of the methylation status can induce cell fate changes. Brief exposure of embryonic fibroblasts to AzaC converts fibroblasts to myoblasts and to a lesser extent to adipocytes and chondrocytes (Lassar et al, 1986) . Further studies into the molecular mechanism of the AzaC-induced myogenic differentiation of fibroblasts led to the identification of the transcription factor MyoD1 as a key regulator of myogenic determination (Thayer et al, 1989) . These results showed that epigenetic modification leads to the conversion of fibroblasts into myoblasts. Our present results support the notion that fate changes of somatic cells can be induced by epigenetic modification.
Neurosphere-derived haematopoietic activity
Our observation that untreated neurosphere cells are unable to generate haematopoietic cells agrees with some previous results but is inconsistent with others. Bjornson et al (1999) reported that in vitro-cultured neurosphere cells are capable of generating haematopoietic cells upon injection into irradiated recipient animals. However, we were unable to detect in transplant recipients of untreated neurospheres any haematopoietic potential that can engraft adult recipients. And similar to our results, two other reports failed to identify neurosphere-derived haematopoietic reconstitution (Morshead et al, 2002; Magrassi et al, 2003) . We do observe however that injection of untreated neurosphere cells into murine blastocysts generates embryos with transient expression in donor cells of globin transgenes and the differentiation of cells that express the erythroid cell surface marker TER119 in chimeric fetal livers and peripheral blood. This indicates that neurosphere-derived donor cells in chimeric tissues display haematopoietic markers when exposed to embryonic microenvironments (Harder et al, 2004) .
It should be emphasized that we employed cultured neurospheres in our analyses. Evidence exists that the potentials of cells such as primordial germ cells and oligodendrocyte precursor cells were increased by in vitro culture (Matsui et al, 1992; . Interestingly, cultured neurosphere cells and cultured mesenchymal stem cells (multipotent adult progenitor cells, MAPCs) were also reported to generate unrelated cell types when injected into blastocysts (Clarke et al, 2000; Jiang et al, 2002) . These cells display the ability to change tissue-specific cell characteristics and they can cross germ layer borders. The multipotentiality of neurosphere cells and MAPCs is associated with in vitro culture, which was shown to result in epigenetic changes (Jost et al, 2001) . It is therefore possible that freshly isolated stem cells are committed to one stem cell system and that they acquire broader lineage potentials only after extended time in culture. Thus, while our experiments give some insights into the þ splenocytes of a clone 2 recipient (6 months post-transplant) were grown in vitro and analysed. (C) Allele-specific FACS analysis of peripheral blood cells of a transplant recipient of bulk TSA/AzaC neurosphere cells (panels 6-8) or splenocytes of a TSA/AzaC clone 1 recipient (panels 9-11). Shown are cells stained with anti-CD45.1 and anti-CD45.2 antibody (panels 6 and 9) and with either anti-CD45.1 (panels 7 and 10) or anti-CD45.2 (panels 8 and 11) antibody and plotted against eGFP. Animals shown were analysed 3-5 months after transplantation. developmental potentials of cultured neurospheres, we did not investigate whether freshly isolated neurosphere cells can contribute to the haematopoietic lineage after treatment and transplantation.
We established neurospheres from bcl2-transgenic mice because it has been shown that bcl2 expression confers protection against apoptosis-inducing challenges (Domen et al, 1998) . Since both wt and bcl2-transgenic neurosphere cells engraft only when treated, it is unlikely that bcl2 transgene expression by itself confers haematopoietic activity to neurospheres. Bcl2 transgene expression increases the in vivo haematopoietic potential of treated neurosphere cells. This may be due to a reduction of apoptosis and a consequent increase of progenitor cell numbers in the injected samples.
But not all adult transplant recipients receiving neurosphere cells were engrafted. The relatively moderate engraftment frequency and the variability of the engraftment levels could indicate that engraftment was due to there being a few repopulating cells in the transplanted samples. The reason for the different engrafting activities of the three clones is unclear, but it might be due to heterogeneity between individual clones or could reflect low fate change frequencies. Altogether, we transplanted in eight independent experiments 25 animals with 0.5 Â10 6 bulk neurosphere cells each and 51 animals with 0.5 Â10 6 clonal cells each, respectively resulting in five and seven engrafted recipients. Since a single HSC is able to engraft the haematopoietic system of a transplant recipient, our available data indicate that the frequency of the haematopoietic system engrafting cells in the injected TSA/AzaC neurosphere cells is 1 per 2.5 Â10 6 in bulk cells and 1 per 3.6 Â10 6 clonal cells. In comparison, fresh bone marrow contains 1-10 engrafting cells per 10 5 cells. Thus, treated neurosphere cultures contain a considerably lower proportion of engrafting cells than fresh bone marrow.
Analysis of treated neurosphere cells in vitro did not generate haematopoietic colonies in methylcellulose cultures supplemented with haematopoietic growth factors. This may indicate that, in order to transdifferentiate, neurosphere cells require the destabilization of the epigenotype and the in vivo haematopoietic microenvironment. TSA/AzaC treatment or transplantation alone is not sufficient for neural-to-haematopoietic transdifferentiation of cultured neurosphere cells.
A series of recent papers reported that somatic stem cells can fuse with ES cells and hepatocytes and generate tetraploid cells (Terada et al, 2002; Ying et al, 2002; Vassilopoulos et al, 2003; Wang et al, 2003) . This led us to test whether after transplantation TSA/AzaC neurosphere cells fuse with recipient haematopoietic cells. We found that most donor-derived haematopoietic cells originating both from bulk and clonal cultures have a 2n DNA content and that neurospherederived splenocytes have a 2n karyotype. Furthermore, in chimeric spleen and peripheral blood, most donor cells show normal expression of eGFP and CD45.2 (chromosomes 1 and 15) but not CD45.1 (chromosome 1). However, a small proportion of donor cells express markers both of donor and recipient cells. Thus, although we cannot rule out cell fusion completely, our data indicate that fusion is not an explanation for the haematopoietic reconstitution.
Molecular prerequisites for neurosphere-derived haematopoiesis
Interestingly, it has been demonstrated that different somatic stem cell types express distinct as well as overlapping transcriptional repertoires (Terskikh et al, 2001; Ivanova et al, 2002; Ramalho-Santos et al, 2002; D'Amour and Gage, 2003) . In addition to the subsets of genes commonly expressed in all somatic stem cells, the TSA/AzaC-induced fate change of neurosphere cells might be caused by either an increase in the expression of genes already expressed or the activation of genes involved in survival and differentiation in haematopoietic microenvironments. After TSA plus AzaC treatment, some cells may show, in addition to a neural transcript repertoire, transcription of further loci. This, together with existing signalling components, could further enhance and stabilize expression of loci appropriate for the new haematopoietic microenvironment. Distinct molecular interactions provided by the new environment could then trigger the differentiation of haematopoietic cell types from treated cells.
In conclusion, our data indicate that transient incubation of cultured neurosphere cells with chromatin-modifying agents enables the generation of neurosphere-derived haematopoietic cells in vivo.
Materials and methods

Establishment of bulk and clonal neurospheres and isolation of bone marrow cells
Bulk neurospheres were established from individually isolated E 14.5 forebrains of male CD45.1 wt embryos or male CD45.2 embryos that carry eGFP and human bcl2 transgenes (Okabe et al, 1997; Domen et al, 1998) as described (Reynolds and Weiss, 1992; Kirchhof et al, 2002) . To eliminate any differences between mouse strains, transgenic mice were backcrossed with C57BL/6 mice (Charles River). Cells were cultured in NSC medium consisting of neural basal medium (Life Technologies) supplemented with B27 (2% v/v) (Life Technologies), penicillin/ampicillin (100 U/ml) (Gibco), streptomycin (100 mg/ml) (Gibco), L-glutamine (2 mM) (Gibco), bFGF (20 ng/ml) (Cell Concepts) and EGF (20 ng/ml) (Cell Concepts). wt neurospheres were passaged about once per week while bcl2-transgenic neurospheres, which grow faster, were passaged every 2-3 days. Clonal cultures were established by plating dissociated neurosphere cells of a bulk eGFP/bcl2 culture individually into wells of 96-well plates by limiting dilution. A cell concentration was prepared that seeded in about 30% of the wells a single cell while the rest of the wells remained empty. The presence of a single cell per well was confirmed by microscopy. Then, the single cells were expanded. wt neurosphere cells were of passages 10-15 and bulk eGFP/bcl2 neurosphere cells were of passages 15-30; however, cloned eGFP/bcl2 neurosphere cells were established from bulk cultures after 20 passages and further expanded for 12-18 passages. For isolation of bone marrow cells, mice were killed, tibiae and femura were flushed with PBS and erythrocytes were lysed by incubation in Gey's solution.
Differentiation of neurosphere cells
Differentiation was carried out by plating neurosphere cells on slides coated with poly-ornithine. Differentiation media consisted of neural basal medium (Life Technologies) supplemented with B27 (2% v/v) (Life Technologies), penicillin (100 U/ml) (Gibco), streptomycin (100 mg/ml) (Gibco), L-glutamine (2 mM) (Gibco) and 10% murine neural stem cell differentiation supplement (Stem Cell Tech.). Differentiation proceeded for 6-8 days.
TSA and AzaC treatment of neurosphere cells
Before treatment, single-cell suspensions were prepared by enzymatic dissociation of neurospheres with Accumax (PAA Laboratories). Cells were counted and seeded at a concentration of 1 Â10 5 cells/ml. For treatment, 150 nM TSA (Sigma) plus 500 nM AzaC (Sigma) were added to the culture medium for 2 days, while control flasks were left untreated.
Western blot analyses
For Western blot analysis, nuclear lysates were prepared with histone isolation buffer (10 mM Tris-HCl, pH 6.5, 1% Triton X-100, 10 mM MgCl 2 , 250 mM sucrose, 20 mM NaHSO 3 ) followed by protein extraction in 28.5 mM Tris-HCl, pH 7.4, 47 mM EDTA and 1% H 2 SO 4 conc. The protein content was quantified using the quantiPro BCA assay kit (Sigma-Aldrich). Equal protein amounts were separated electrophoretically on a 12% SDS-PAA gel and transferred to nitrocellulose membranes. After blocking with 5% skim milk, membranes were probed with anti-acetyl histone H4 rabbit antiserum (recognizing acetylation on K5, 8, 12 and 16) (Upstate Biotechnology) and anti-MeCP2 polyclonal rabbit antibody (Upstate Biotechnology), washed and incubated with horseradish peroxidaseconjugated bovine anti-rabbit antibody (Santa Cruz). Membranes were developed using ECL reagents (Amersham Biosciences). After stripping of membranes, equal loading of the lanes was verified using anti-histone H4 polyclonal rabbit antibody (Upstate Biotechnology). 6 CD45 congenic control bone marrow cells were injected into the tail vein. Secondary recipients received lethal irradiation (11.5 Gy, split dose) and 1 Â10 5 to 8 Â10 6 bone marrow cells from primary transplant recipients. Animals were given an antibiotic (neomycin sulphate; Applichem) in the drinking water for 2 days before and 2 weeks after irradiation. All animal experimentation was carried out according to permitted procedures (Government of Unterfranken, Wü rzburg, Germany).
Analysis of donor contribution
For FACS analysis, single-cell suspensions were prepared from thymus, spleen and bone marrow in ice-cold PBS/0.3% BSA. Whole blood was isolated in PBS/5 mM EDTA. Where appropriate, erythrocytes were lysed by incubation in Gey's solution. Cells were rinsed with FACS buffer (PBS supplemented with 0.4% BSA and 0.02% NaN 3 , pH 7.4), and, after blocking of Fc receptors (FcgRIII/ II) with 2.4G2 antibody, 5 Â10 5 cells were added to 50 ml of FACS buffer supplemented with the appropriate primary antibodies and incubated at 41C for 30 min. After washing, to detect biotinylated primary antibodies streptavidin-R-PE (Gibco), streptavidin-Red670 (Gibco) or streptavidin-APC (BD PharMingen) was added for incubation at 41C for 30 min. The following antibodies were used: CD3-biotin, CD3-PE (145-2C11, BD PharMingen), CD4-biotin (RM4-5), CD8-PE (53-6.7, BD PharMingen), CD19-biotin, CD19-PE (1D3, BD PharMingen), CD45.1-PE (A20, BD PharMingen), CD45. . Male-specific PCR was performed on genomic DNA as described (Geiger et al, 1998) .
Methylcellulose cultures and morphological analysis Cells were seeded in 1 ml of methylcellulose (MethoCult M3134, Stem Cell Tech.) containing 30% FCS, 1% BSA, 10 À4 M 2-ME and 10 ng/ml rmIL3 (PeproTech). Where indicated, cultures were supplemented with 4 U/ml rmEPO and 2% pokeweed mitogen murine-spleen cell-conditioned medium (PWM-SCCM, Stem Cell Tech.) or 2% PWM-SCCM alone. Cell suspensions were grown for 9-12 days. For morphological analysis of neurosphere-derived bone marrow cells, CD45.2 þ donor cells were FACS-sorted (BD FACS Vantage SE system), Cytospin preparations were made and slides were stained with DiffQuik (Baxter).
DNA content and M-FISH analysis
Spleens were isolated, and after erythrocyte lysis with Gey's solution, single-cell suspensions were prepared. Where indicated, splenocytes were stimulated with concanavalin A (5 mg/ml, Sigma) and human IL2 (50 U/ml, Strathman Biotech) in complete RPMI 1640 medium (10% FCS, 2 mM L-glutamine, 10 mM Hepes, 100 U/ ml penicillin/streptomycin) for 3-5 days. After blocking Fc receptors (FcgRIII/II) with 2.4G2 antibody, 1 Â10 6 splenocytes were stained with biotinylated anti-CD45.2 (104, BD PharMingen) and, for biotin detection, with streptavidin-R-PE (Gibco). Subsequently, the cellular DNA was labelled by a combination of 7-AAD (Sigma) and actinomycin D (AD, Sigma) (Schmid et al, 2000) . Samples were measured with a Becton Dickinson FACS Calibur TM equipped with a Doublet Discrimination module for exclusion of cell clumps. Gated on the singlet cell population, the specific fluorescence signals were analysed with Becton Dickinson CellQuest TM software. Metaphase spreads were prepared from sorted and concanavalin A/Il2-stimulated splenocytes. For M-FISH analysis, mouse chromosomespecific painting probes were combinatorially labelled using seven different fluorochromes and hybridized as described (Jentsch et al, 2003) . Images of 20 metaphase spreads were acquired using a Leica DM RXA epifluorescence microscope (Leica, Bensheim, Germany) equipped with a Sensys CCD camera (Photometrics, Tucson, AZ) and controlled by the Leica Q-FISH software (Leica Microsystems Imaging Solution, Cambridge, UK). Image processing and karyotyping were performed using the Leica MCK software.
